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COMPULSIVE DISORDER: SEVEN VS. TWELVE-WEEK
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Previous research has demonstrated that individualized behavioral exposure
and response prevention therapy is an effective treatment for Obsessive-Com-
pulsive Disorder. In our prior preliminary report, 7-week group exposure and
response prevention therapy was also found effective in reducing obsessions and
compulsions. The present report describes a larger sample (N=113) of treat-
ment seeking obsessive-compulsives who received group behavioral therapy. As
before, group exposure and response prevention significantly improved ratings
of obsessions, compulsions, and depression. These improvements were main-
tained at 3-month and long-term follow-up. A sub-sample of patients who
received 12 weeks of treatment had outcomes at the end of the group and at
follow-up that did not significantly differ from those who received 7 weeks of
treatment. These results confirm the efficacy of a 7-week behavioral treatment
program administered in a group format. Depression and Anxiety 13:161–
165, 2001. © 2001 Wiley-Liss, Inc.
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INTRODUCTION
I ndividual behavioral exposure and response preven-
tion for Obsessive-Compulsive Disorder (OCD) has
been established as an effective treatment method
[Rachman and Hodgson, 1980; Foa et al., 1984]. In
our prior preliminary report, we found that a 7-week
behavioral group program was an effective treatment
for OCD in a sample of 36 patients [Krone et al.,
1991]. Similar rates of improvement were observed for
patients who were taking medication vs. those who
were not.
Six other reports have been published that describe
behavioral group treatment of obsessive-compulsive
disorder. In an uncontrolled case series, Hand and
Tichatzky [1979] reported improved OCD symptoms
among patients who participated in a 30 week, three
phase, outpatient treatment program, which included
both individual and group exposure sessions. The
group treatment component involved three group for-
mats, therapist lead groups, consumer lead groups,
and a group for only family members. Epsie [1986], in
another uncontrolled study, reported significant im-
provement from a 10-week group treatment for pa-
tients who had relapsed after previously benefiting
from individual behavioral treatment. Improvement
was maintained at up to 1-year follow-up. Enright
[1991] found only modest reduction of OCD symp-
toms among patients given group cognitive-behavioral
therapy. This group included additional behavioral
treatments beyond exposure and response prevention
therapy, including stress management techniques and
assertiveness training. Fals-Stewart et al. [1993], in the
first controlled study of group behavioral therapy for
OCD, found group exposure and response prevention
more effective than relaxation therapy but somewhat
less effective than individual behavioral treatment in
reducing OCD symptoms. Patients with co-morbid
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depression were excluded from this study. This is a sig-
nificant issue, given that OCD and depression very of-
ten co-occur [Karno and Golding, 1991]. Van Noppen
and associates [1997], highlighting the significance of
family issues in OCD, compared a 10 session group
that included OCD patients and their family members
to a similar group without family participation. Both
groups improved but patients in the family group
were more likely to meet study criteria for clinically
significant improvement. Finally, Van Noppen et al.
[1998], in an uncontrolled naturalistic study of a 10-
week behavioral group, found significant improve-
ment in obsessions and compulsions. Those patients
receiving medication showed greater improvement
than those who were medication-free.
The present paper adds to the growing literature on
group treatment of OCD by addressing the optimal
duration of group behavioral therapy. This paper
compares the efficacy of a 7 vs. 12-week group behav-
ioral therapy program in 113 subjects who presented
for treatment of OCD.
METHOD
SUBJECTS
The 113 patients who participated in the group
treatment program were outpatients at the University
of Michigan Anxiety Disorders Program. All received
a primary diagnosis of Obsessive-Compulsive Disor-
der [American Psychiatric Association, 1994] from
both an experienced clinician and a faculty psychiatrist
who specialize in the diagnosis and treatment of anxi-
ety disorders. Eighty-nine patients participated in the
7-week program and 24 participated in the 12-week
program. Patients were assigned to the 7- and 12-
week groups consecutively. The patients were not
given a choice as to which group (7 week vs. 12 week)
they attended. The sample included 70 women and 43
men and the mean age at intake was 37 (SD = 10.86)
years. Sixty-eight of the patients were taking medica-
tion for their OCD symptoms concurrent with group
participation.
GROUP TREATMENT
As described in our prior report [Krone et al., 1991],
the group therapy sessions included the following: 1)
education about OCD and its treatment, 2) instruc-
tion in the behavioral approach to the self-treatment
of OCD, and 3) therapist guided and group supported
individualized behavior therapy planning. Participants
received workbooks containing educational material
and forms for recording behavioral exercises. A treat-
ment manual is available by contacting the corre-
sponding author.
The 7-week group met weekly for 2 hours. The first
hour included education about OCD and its treat-
ment. Educational topics included: (week 1) the nature
of OCD and the principles of behavior therapy; (week
2) causes of OCD; (week 3) other treatments for
OCD; (week 4) family life and OCD; (week 5) special-
ized techniques for making behavior therapy more ef-
fective; and (week 6) lifestyles and OCD. The seventh
educational session involved a summary and review of
the previous sessions. The second hour of the group
was devoted to behavioral treatment. During this
hour, the principles of behavioral exposure and re-
sponse prevention were used to design individualized
treatment programs for each participant. These ses-
sions included behavioral analysis of OCD symptoms,
development of goals for behavioral treatment, and
formulation of behavioral exercises to be completed as
homework. In addition to homework assignments,
brief in vivo exposure exercises were conducted in or-
der to assist participants in initiating difficult assign-
ments, in overcoming obstacles to treatment, or when
the presence of group members facilitated exposure.
During later group sessions, patients were encouraged
to design their own behavioral exercises, with assis-
tance from the therapist.
The 12-week program included a similar 7-week, 2
hour, course of education and behavioral treatment
planning, augmented by five extra 1-hour sessions.
These sessions involved a continuation of the behavior
therapy planning portion of the group.
Finally, both groups included a 2-hour family ses-
sion. During this evening session, family members
were given information about the nature of OCD and
its treatment. In addition, patients and their families
discussed family issues related to OCD and how these
might be effectively addressed.
MEASURES
Obsessive-Compulsive and depressive symptoms
were rated before entry into the group, upon group
completion, 3 months after treatment completion, and
at long-term follow-up (mean follow-up length =
49.19 months; SD = 16.64 months). Pre- and post-
group ratings were obtained in person and follow-up
ratings were obtained over the telephone. OCD symp-
toms were rated using the Yale-Brown Obsessive-
compulsive Inventory (Y-BOCS) [Goodman et al.,
1989]. Depression symptoms were evaluated using the
Beck Depression Inventory (BDI) [Beck et al., 1961], a
widely used self-report instrument for assessing sever-
ity of depression.
STATISTICAL ANALYSIS
Analyses of variance for repeated measures, Student’s
t-tests, and chi-square analyses were used as indicated.
The repeated measures analyses were conducted by us-
ing the SAS statistical software package and the PROC
MIXED technique. Owing to limited space, only espe-
cially important repeated analyses will be reported.
RESULTS
Selected demographic variables, Y-BOCS scores,
and BDI scores are presented in Table 1. There were
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no significant differences in sex ratio (df = 1, chi-
square = 1.02, P = .312), mean age (df = 111; t = –0.24,
P = .810), initial Y-BOCS score (df = 111; t = 0.15, P =
.885), and initial BDI score (df = 102; t = –1.40, P =
.165) between members who participated in the 7 vs.
the 12-week program. There was also no significant
difference in medication status between the two
groups (df = 1, chi-square = 1.31, P = .252) (58%
medication, 7-week group; 71% medication, 12-week
group).
The data were first analyzed for the entire sample of
group participants regardless of whether they received
the 7 (n = 89) or 12 (n = 24) week program. Significant
reductions in Y-BOCS and Beck Depression scores
were observed for subjects following treatment and
these differences were maintained through long-term
follow-up. Analysis of variance for repeated measures
showed a significant difference over time in Y-BOCS
total (df = 3, 196; F = 58.70; P < 0.0001), Y-BOCS
obsession (df = 3, 196; F = 48.30; P < 0.0001), Y-
BOCS compulsion (df = 3, 196; F = 55.5; P < 0.0001),
and Beck depression (df = 3, 173; F = 18.1; P < 0.0001)
scores. A second repeated measures analysis of vari-
ance (group × time period interaction) failed to find a
significant difference in outcome for those who were
taking medication compared to those who were not
(Y-BOCS total (df = 1, 82; F = 0.84; P = .363); Y-
BOCS compulsion (df = 1, 82; F = 1.88; P = .174); Y-
BOCS obsession (df = 1, 82; F = 0.65; P = 0.421); Beck
Depression (df = 1, 68; F = 0.62; P = 0.434).
A third analysis was performed by using the baseline
score as a covariate in the repeated measures analysis.
Coefficients less than one for all outcome measures
(Y-BOCS total, beta = 0.61; Y-BOCS obsession, beta =
0.49; and Y-BOCS compulsion, beta = 0.66) indicated
that patients with the most severe OCD symptoms at
baseline achieved the largest improvements.
No significant differences in outcome were ob-
served between the 7-week and the 12-week treatment
groups (Fig 1). Analyses of variance for repeated mea-
sures (group × time period interaction) did not show a
significant difference between the two groups in Y-
BOCS total (df = 1, 84; F = 1.62; P = .207), Y-BOCS
obsession (df = 1, 84; F = 0.00; P = 0.997), Y-BOCS
compulsion (df = 1, 84; F = 0.02; P = 0.900), or Beck
depression scores (df = 1, 69; F = 2.96; P = 0.090).
DISCUSSION
This study provides evidence that short-term group
behavioral therapy is an efficient and effective form of
treatment for obsessive-compulsive disorder. Significant
improvements in Yale-Brown scores were found for
both the 7 and 12-week groups. Significant improve-
ments in Beck Depression scores were also observed.
The amount of improvement in obsessive-compulsive
and depressive symptoms was not influenced by whether
subjects were taking medication. The findings of this
study are also consistent with other reports indicating
the effectiveness of group behavioral treatment for
OCD [Hand and Tichatzky, 1979; Epsie, 1986; Fals-
Stewart et al., 1993; Van Noppen et al., 1997, 1998].
The improvement in obsessive-compulsive symptoms
from the beginning to the end of the group is similar to
that observed in other studies of behavioral and pharma-
cological treatment for OCD [Abramowitz, 1997].
TABLE 1. YBOCS and BDI scores*
All subjects 7 week group 12 week group
Measures n Mean (SD) n Mean (SD) n Mean (SD)
Y-BOCS
Time 1 113 22.27 (6.60) 89 22.32 (6.53) 24 22.08 (7.01)
Time 2 113 15.47 (6.53) 89 15.62 (6.47) 24 14.92 (6.83)
Time 3 60 13.88 (7.94) 45 13.34 (7.23) 15 15.47 (9.89)
Time 4 26 14.62 (6.81) 15 15.27 (5.96) 11 13.73 (8.04)
Y-BOCS obsession
Time 1 113 11.08 (3.72) 89 11.00 (3.92) 24 13.83 (2.79)
Time 2 113 7.83 (3.73) 89 7.87 (3.75) 24 7.71 (3.72)
Time 3 60 7.08 (4.03) 45 6.70 (3.81) 15 8.23 (4.57)
Time 4 26 7.52 (3.74) 15 7.83 (3.46) 11 7.09 (4.21)
Y-BOCS compulsion
Time 1 113 11.20 (3.57) 89 11.28 (3.26) 24 10.88 (4.61)
Time 2 113 7.81 (3.62) 89 7.98 (3.58) 24 7.21 (3.78)
Time 3 60 6.80 (4.45) 45 6.66 (3.98) 15 7.23 (5.77)
Time 4 26 7.00 (3.67) 15 7.43 (3.45) 11 6.64 (4.08)
Beck Depression Inventory
Time 1 104 15.89 (9.37) 83 15.24 (8.82) 21 18.43 (11.18)
Time 2 101 11.14 (9.71) 82 10.21 (8.33) 19 15.16 (13.81)
Time 3 55 10.47 (10.73) 42 8.83 (8.94) 13 15.77 (14.34)
Time 4 26 10.89 (8.31) 15 10.47 (7.86) 11 11.46 (9.26)
*Time 1, begin group; Time 2, end group; Time 3, 3 month follow-up; Time 4, long term follow-up.
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Extending the duration of the group to 12 weeks did
not enhance eventual outcome. Clinical impressions
suggest that patients in the 12-week group paced
themselves more slowly with the behavioral exposure
and response prevention exercises and also were absent
from the group more often than patients attending the
7-week program. Apart from saving time, the reduc-
tion in number of sessions resulted in a cost saving of
$350.00 per case treated (this savings assumes atten-
dance/billing for all sessions). Clearly, longer is not al-
ways better with respect to group behavioral treatment
for OCD patients. This result stands in contrast to
what our patients expected. The 12-week program was
initiated after several members who received the 7-
week group expressed the desire for an extended for-
mat. The fact that the shorter treatment program was
as effective as the extended format may have implica-
tions for other conditions and methods of treatment.
Also, it would be interesting to learn if seven sessions
are more effective than five or three. It would not be
surprising if fewer sessions could be effective given
that anxiety disorders often respond to self-conducted
behavioral programs [Ghosh and Marks, 1987].
The present study also demonstrated that most pa-
tients maintained gains made during the group at
long-term follow-up. Maintenance of gains was appar-
ent for both the seven and 12-week groups. However,
caution is advised when interpreting our long-term
follow-up data given the small number of patients who
participated. It is extremely difficult to obtain long-
term follow-up data in a naturalistic study with a tran-
sient population of subjects but the available data was
included given the importance of tracking long-term
outcome. However, it is important to note that pa-
tients who provided long-term follow-up data did not
significantly differ in response to treatment compared
to those who did not provide long-term follow-up.
Given that OCD is not known to respond to inert
treatments [Katz et al., 1990], it is unlikely that the
observed improvement in this study resulted from
non-specific effects. However, future controlled stud-
ies, with random assignment, of the 7-week treatment
model are needed to further confirm the efficacy of
the treatment program. In addition to comparison to a
credible attention control group, the outcomes of this
treatment model must be compared with other effec-
tive treatments such as individual behavior therapy
[Rachman and Hodgson, 1980; Foa et al., 1984] and
medication [Pigott et al., 1990; Insel, 1990]. Similarly,
it would be useful to explore further whether a combi-
nation of medication and group behavioral treatment
has additional benefit over group treatment alone.
Despite the limitations of this study, it demonstrates
the utility of short-term behavioral group therapy as an
effective and efficient treatment of obsessive-compul-
sive disorder. In addition, the study provides important
data regarding the appropriate length of group behav-
ioral therapy for OCD. The group program is standard-
ized, easily implemented, and requires less therapist
time than individual behavioral treatment.
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